Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea
NCT02601963
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
233
Enrollment
INDUSTRY
Sponsor class
Conditions
Rosacea
Papulopustular Rosacea
Interventions
DRUG:
FMX-103 1.5%
DRUG:
FMX-103 3%
DRUG:
Vehicle foam (0%)
Sponsor
Vyne Therapeutics Inc.